Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Performance of antenatal imaging to predict placenta accreta spectrum degree of severity

O. Morel, HJ. van Beekhuizen, T. Braun, S. Collins, P. Pateisky, P. Calda, W. Henrich, A. Al Naimi, L. Nikoline Norgaardt, KM. Chalubinski, L. Sentilhes, B. Tutschek, A. Schwickert, V. Stefanovic, C. Bertholdt, International Society for Placenta...

. 2021 ; 100 Suppl 1 (-) : 21-28. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019111

INTRODUCTION: In cases of placenta accreta spectrum, a precise antenatal diagnosis of the suspected degree of invasion is essential for the planning of individual management strategies at delivery. The aim of this work was to evaluate the respective performances of ultrasonography and magnetic resonance imaging for the antenatal assessment of the severity of placenta accreta spectrum disorders included in the database. The secondary objective was to identify descriptors related to the severity of placenta accreta spectrum disorders. MATERIAL AND METHODS: All the cases included in the database for which antenatal imaging data were available were analyzed. The rates of occurrence of each ultrasound and magnetic resonance imaging descriptor were reported and compared between the Group "Accreta-Increta" (FIGO grades 1 & 2) and the Group "Percreta" (FIGO grade 3). RESULTS: Antenatal imaging data were available for 347 women (347/442, 78.5%), of which 105 were included in the Group "Accreta - Increta" (105/347, 30.2%) and 213 (213/347, 61.4%) in the Group "Percreta". Magnetic resonance imaging was performed in addition to ultrasound in 135 women (135/347, 38.9%). After adjustment for all ultrasound descriptors in multivariate analysis, only the presence of a bladder wall interruption was associated with a significant higher risk of percreta (Odds ratio 3.23, Confidence interval 1.33-7.79). No magnetic resonance imaging sign was significantly correlated with the degree of severity. CONCLUSIONS: The performance of ultrasound and magnetic resonance imaging to discriminate mild from severe placenta accreta spectrum disorders is very poor. To date, the benefit of additional magnetic resonance imaging has not been demonstrated.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019111
003      
CZ-PrNML
005      
20210830100707.0
007      
ta
008      
210728s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/aogs.14112 $2 doi
035    __
$a (PubMed)33811333
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Morel, Olivier $u Women's Division, Nancy Regional University Hospital (CHRU), Université de Lorraine, and Diagnosis and International Adaptive Imaging (IAD), Inserm, Université de Lorraine, Nancy, France
245    10
$a Performance of antenatal imaging to predict placenta accreta spectrum degree of severity / $c O. Morel, HJ. van Beekhuizen, T. Braun, S. Collins, P. Pateisky, P. Calda, W. Henrich, A. Al Naimi, L. Nikoline Norgaardt, KM. Chalubinski, L. Sentilhes, B. Tutschek, A. Schwickert, V. Stefanovic, C. Bertholdt, International Society for Placenta Accreta Spectrum (IS-PAS)
520    9_
$a INTRODUCTION: In cases of placenta accreta spectrum, a precise antenatal diagnosis of the suspected degree of invasion is essential for the planning of individual management strategies at delivery. The aim of this work was to evaluate the respective performances of ultrasonography and magnetic resonance imaging for the antenatal assessment of the severity of placenta accreta spectrum disorders included in the database. The secondary objective was to identify descriptors related to the severity of placenta accreta spectrum disorders. MATERIAL AND METHODS: All the cases included in the database for which antenatal imaging data were available were analyzed. The rates of occurrence of each ultrasound and magnetic resonance imaging descriptor were reported and compared between the Group "Accreta-Increta" (FIGO grades 1 & 2) and the Group "Percreta" (FIGO grade 3). RESULTS: Antenatal imaging data were available for 347 women (347/442, 78.5%), of which 105 were included in the Group "Accreta - Increta" (105/347, 30.2%) and 213 (213/347, 61.4%) in the Group "Percreta". Magnetic resonance imaging was performed in addition to ultrasound in 135 women (135/347, 38.9%). After adjustment for all ultrasound descriptors in multivariate analysis, only the presence of a bladder wall interruption was associated with a significant higher risk of percreta (Odds ratio 3.23, Confidence interval 1.33-7.79). No magnetic resonance imaging sign was significantly correlated with the degree of severity. CONCLUSIONS: The performance of ultrasound and magnetic resonance imaging to discriminate mild from severe placenta accreta spectrum disorders is very poor. To date, the benefit of additional magnetic resonance imaging has not been demonstrated.
650    _2
$a kohortové studie $7 D015331
650    _2
$a databáze faktografické $7 D016208
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční tomografie $x normy $7 D008279
650    _2
$a placenta accreta $x klasifikace $x diagnostické zobrazování $7 D010921
650    _2
$a těhotenství $7 D011247
650    _2
$a prenatální diagnóza $x metody $7 D011296
650    _2
$a senzitivita a specificita $7 D012680
650    12
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a ultrasonografie prenatální $x normy $7 D016216
651    _2
$a Evropa $7 D005060
651    _2
$a Spojené státy americké $7 D014481
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
700    1_
$a van Beekhuizen, Heleen J $u Department of Gynecological Oncology, Erasmus MC Cancer center, Rotterdam, The Netherlands
700    1_
$a Braun, Thorsten $u Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany $u Department of Obstetrics, Berlin Institute of Health, Berlin, Germany
700    1_
$a Collins, Sally $u Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK and the Fetal Medicine Unit, John Radcliffe Hospital, Oxford, UK
700    1_
$a Pateisky, Petra $u Division of Obstetrics and Feto-Maternal Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
700    1_
$a Calda, Pavel $u Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Henrich, Wolfgang $u Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
700    1_
$a Al Naimi, Ammar $u Department of Obstetrics and Gynecology, Buergerhospital - Dr. Senckenberg Foundation, Frankfurt, Germany $u Department of Obstetrics and Gynecology, University Hospital of the Goethe University of Frankfurt, Frankfurt, Germany
700    1_
$a Nikoline Norgaardt, Lone $u Department of Obstetrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
700    1_
$a Chalubinski, Kinga M $u Division of Obstetrics and Feto-Maternal Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
700    1_
$a Sentilhes, Loic $u Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux, France
700    1_
$a Tutschek, Boris $u Praenatal-Zuerich and Medical Faculty Heinrich Heine University, Duesseldorf, Germany
700    1_
$a Schwickert, Alexander $u Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
700    1_
$a Stefanovic, Vedran $u Department of Obstetrics and Gynecology, Fetomaternal Medical Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
700    1_
$a Bertholdt, Charline $u Women's Division, Nancy Regional University Hospital (CHRU), Université de Lorraine, and Diagnosis and International Adaptive Imaging (IAD), Inserm, Université de Lorraine, Nancy, France
710    2_
$a International Society for Placenta Accreta Spectrum (IS-PAS)
773    0_
$w MED00009026 $t Acta obstetricia et gynecologica Scandinavica $x 1600-0412 $g Roč. 100 Suppl 1, č. - (2021), s. 21-28
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33811333 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100707 $b ABA008
999    __
$a ok $b bmc $g 1690030 $s 1139557
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 100 Suppl 1 $c - $d 21-28 $e - $i 1600-0412 $m Acta obstetricia et gynecologica Scandinavica $n Acta Obstet Gynecol Scand $x MED00009026
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace